rs371054976
Variant summary
Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP6_ModerateBP7BS1BS2
The NM_001127453.2(GSDME):c.687C>T(p.Asp229Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000443 in 1,579,772 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001127453.2 synonymous
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- autosomal dominant nonsyndromic hearing loss 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GSDME | NM_001127453.2 | c.687C>T | p.Asp229Asp | synonymous_variant | Exon 5 of 10 | ENST00000645220.1 | NP_001120925.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GSDME | ENST00000645220.1 | c.687C>T | p.Asp229Asp | synonymous_variant | Exon 5 of 10 | NM_001127453.2 | ENSP00000494186.1 |
Frequencies
GnomAD3 genomes AF: 0.0000301 AC: 4AN: 132908Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000319 AC: 8AN: 250602 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000456 AC: 66AN: 1446864Hom.: 0 Cov.: 32 AF XY: 0.0000487 AC XY: 35AN XY: 719396 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000301 AC: 4AN: 132908Hom.: 0 Cov.: 31 AF XY: 0.0000155 AC XY: 1AN XY: 64344 show subpopulations
ClinVar
Submissions by phenotype
not specified Benign:1
p.Asp229Asp in exon 5 of DFNA5: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, it is not located w ithin the splice consensus sequence, and it is not predicted to impact splicing. It has been identified in 2/66626 European chromosomes and in in 2/11570 Latin o chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstit ute.org; dbSNP rs371054976). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at